Cyteir Therapeutics Inc (CYT) has fallen 0.66% Tuesday In Premarket Trading

Tuesday, November 14, 2023 08:34 AM | InvestorsObserver Analysts

Mentioned in this article

Cyteir Therapeutics Inc (CYT) has fallen 0.66% Tuesday In Premarket Trading

Cyteir Therapeutics Inc (CYT) is lower by Tuesday morning, with the stock decreasing -0.66% in pre-market trading to 3.01. CYT's short-term technical score of 89 indicates that the stock has traded more bullishly over the last month than 89% of stocks on the market. In the Biotechnology industry, which ranks 124 out of 146 industries, the stock ranks higher than 94% of stocks. Cyteir Therapeutics Inc has fallen 1.30% over the past month, closing at $3.01 on October 17. During this period of time, the stock fell as low as $2.98 and as high as $3.08. CYT has an average analyst recommendation of Sell. The company has an average price target of $3.00.

CYT has an Overall Score of 64. Find out what this means to you and get the rest of the rankings on CYT!

See Full CYT Report

Cyteir Therapeutics Inc has a Long-Term Technical rank of 98. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 2% of the market scoring higher. In the Biotechnology industry which is number 126 by this metric, CYT ranks better than 126% of stocks.

Important Dates for Investors in CYT:

-Cyteir Therapeutics Inc is set to release earnings on 2024-02-04. Over the last 12 months, the company has reported EPS of $-0.95. -We do not have a set dividend date for Cyteir Therapeutics Inc at this time. Click Here To Get The Full Report on Cyteir Therapeutics Inc (CYT)